Starting the conversation on gene therapy for phenylketonuria: Current perspectives of patients, caregivers, and advocates.
- DOI
- 10.1016/j.ymgmr.2022.100855
- Published
- 2022 Jun
- Container
- Molecular genetics and metabolism reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ymgmr.2022.100855,
title = {Starting the conversation on gene therapy for phenylketonuria: Current perspectives of patients, caregivers, and advocates.},
author = {Regier DS and Bąk A and Bausell H and O'Reilly E and Cowsert LM},
year = {2022},
journal = {Molecular genetics and metabolism reports},
doi = {10.1016/j.ymgmr.2022.100855},
url = {https://doi.org/10.1016/j.ymgmr.2022.100855}
}RIS
TY - JOUR TI - Starting the conversation on gene therapy for phenylketonuria: Current perspectives of patients, caregivers, and advocates. AU - Regier DS AU - Bąk A AU - Bausell H AU - O'Reilly E AU - Cowsert LM PY - 2022 JO - Molecular genetics and metabolism reports DO - 10.1016/j.ymgmr.2022.100855 UR - https://doi.org/10.1016/j.ymgmr.2022.100855 ER -
APA
DS, R., A, B., H, B., E, O., & LM, C. (2022). Starting the conversation on gene therapy for phenylketonuria: Current perspectives of patients, caregivers, and advocates.. Molecular genetics and metabolism reports. https://doi.org/10.1016/j.ymgmr.2022.100855
Source records
- pubmed · retrieved 2026-09-27T12:24:07.173Z